Comments
Loading...

Cyclacel Pharmaceuticals

CYCCNASDAQ
Logo brought to you by Benzinga Data
$0.361400
-0.01-3.37%
At close: -
$0.356100
-0.0053-1.47%
After Hours: 7:56 PM EDT
Q3 2024 Earnings were released on Tue Nov 12th, after the market close

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Cyclacel Pharmaceuticals (CYCC)?

A

There have been no specific sales or earnings guidance reported for Cyclacel Pharmaceuticals in recent months.

Browse guidance and forecast on all stocks.

People Also Watch